We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVA icon
1776
Privia Health
PRVA
$3.04B
$164K ﹤0.01%
7,973
+3,482
+78% +$78.5K
LCII icon
1777
LCI Industries
LCII
$2.59B
$164K ﹤0.01%
1,333
+389
+41% +$53.2K
QQQA icon
1778
ProShares Nasdaq-100 Dorsey Wright Momentum ETF
QQQA
$66.5M
$164K ﹤0.01%
3,228
-5,358
-62% -$283K
QLYS icon
1779
Qualys
QLYS
$4.76B
$164K ﹤0.01%
1,862
-194
-9% -$21.5K
NEOG icon
1780
Neogen
NEOG
$2.05B
$163K ﹤0.01%
17,589
+1,187
+7% +$11.7K
CECO icon
1781
Ceco Environmental
CECO
$3.49B
$163K ﹤0.01%
2,741
+1,660
+154% +$107K
USLM icon
1782
United States Lime & Minerals
USLM
$3.24B
$163K ﹤0.01%
1,249
+1,065
+579% +$128K
RXO icon
1783
RXO
RXO
$3.68B
$163K ﹤0.01%
11,150
+7,703
+223% +$113K
VCEL icon
1784
Vericel Corp
VCEL
$2.38B
$163K ﹤0.01%
5,063
+457
+10% +$16.2K
RARE icon
1785
Ultragenyx Pharmaceutical
RARE
$2.46B
$163K ﹤0.01%
7,773
+7,766
+110,943% +$175K
WAFD icon
1786
WaFd
WAFD
$2.71B
$162K ﹤0.01%
5,173
+2,663
+106% +$85.7K
CRL icon
1787
Charles River Laboratories
CRL
$11.3B
$162K ﹤0.01%
938
-1,542
-62% -$286K
MQ icon
1788
Marqeta
MQ
$1.93B
$162K ﹤0.01%
9,915
+450
+5% +$7.58K
HLIO icon
1789
Helios Technologies
HLIO
$2.47B
$162K ﹤0.01%
2,499
+784
+46% +$52.5K
GEF icon
1790
Greif
GEF
$4.95B
$161K ﹤0.01%
2,407
-1,132
-32% -$80.2K
FBNC icon
1791
First Bancorp
FBNC
$2.61B
$161K ﹤0.01%
2,863
-1,458
-34% -$83.1K
GERN icon
1792
Geron
GERN
$898M
$161K ﹤0.01%
108,172
+42,365
+64% +$64.4K
ANAB icon
1793
AnaptysBio
ANAB
$1.54B
$161K ﹤0.01%
2,898
+2,171
+299% +$117K
UFIV icon
1794
US Treasury 5 Year Note ETF
UFIV
$29.2M
$161K ﹤0.01%
3,289
-22,224
-87% -$1.09M
ROM icon
1795
ProShares Ultra Technology
ROM
$1.01B
$160K ﹤0.01%
+2,047
New +$183K
PNR icon
1796
Pentair
PNR
$10.6B
$160K ﹤0.01%
1,841
-4,836
-72% -$474K
NCNO icon
1797
nCino
NCNO
$2.06B
$160K ﹤0.01%
10,683
+8,468
+382% +$159K
EXTR icon
1798
Extreme Networks
EXTR
$3.8B
$160K ﹤0.01%
10,594
-189
-2% -$2.82K
EPAM icon
1799
EPAM Systems
EPAM
$5.58B
$160K ﹤0.01%
1,178
-1,410
-54% -$241K
EOSE icon
1800
Eos Energy Enterprises
EOSE
$1.14B
$159K ﹤0.01%
32,136
+23,375
+267% +$251K

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.